Contact
Please use this form to send email to PR contact of this press release:
Stemline Therapeutics Announces that FDA Accepts ELZONRIS™ Biologics License Application (BLA) and Grants Priority Review
TO:
Please use this form to send email to PR contact of this press release:
Stemline Therapeutics Announces that FDA Accepts ELZONRIS™ Biologics License Application (BLA) and Grants Priority Review
TO: